Argitalpenak (62) CRISTINA BLÁZQUEZ ORTIZ argitalpenak

2024

  1. GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

    Journal of Neuroscience, Vol. 44, Núm. 39

  2. Ingeniería Genética en H5P: promoviendo la participación del alumnado a través de la ludificación

    III Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 157-168

  3. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

2023

  1. Ludificación y mentoría en Ingeniería Genética: construcción de unjuego docente sobre la infraestructura LAMP

    II Jornada «Aprendizaje Eficaz con TIC en la UCM» (Ediciones Complutense), pp. 41-52

  2. Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling

    Cancers, Vol. 15, Núm. 9

2022

  1. The phantom menace: cómo salvar el mundo de una pandemia mediante ingeniería genética cooperativa.

    Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 301-311

2020

  1. Cannabinoid-induced motor dysfunction via autophagy inhibition

    Autophagy, Vol. 16, Núm. 12, pp. 2289-2291

  2. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination

    eLife, Vol. 9, pp. 1-24

2016

  1. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling

    Neuropharmacology, Vol. 108, pp. 345-352

  2. Sustained Gq-protein signaling disrupts striatal circuits via JNK

    Journal of Neuroscience, Vol. 36, Núm. 41, pp. 10611-10624

2015

  1. The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

    Cell Death and Differentiation, Vol. 22, Núm. 10, pp. 1618-1629

2014

  1. A restricted population of CB1 cannabinoid receptors with neuroprotective activity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 22, pp. 8257-8262

2013

  1. Feasibility and safety of hospital discharge 24 hours after laparoscopic radical prostatectomy

    Archivos Espanoles de Urologia, Vol. 66, Núm. 10, pp. 931-938

  2. Resultados oncológicos en pacientes potencialmente candidatos a vigilancia activa sometidos a prostatectomía radical

    Actas Urologicas Espanolas, Vol. 37, Núm. 10, pp. 603-607

  3. Vigilancia activa en cáncer de próstata de bajo riesgo. Aceptación por el paciente y resultados

    Actas Urologicas Espanolas, Vol. 37, Núm. 9, pp. 533-537

  4. Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour

    BJU International, Vol. 111, Núm. 4 B

2011

  1. External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer

    World Journal of Urology, Vol. 29, Núm. 4, pp. 409-414

  2. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: A randomized clinical trial with 2-year follow-up

    European Urology, Vol. 60, Núm. 4, pp. 734-739

  3. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease

    Brain, Vol. 134, Núm. 1, pp. 119-136

  4. Reply: Reliability of immunolabelling in the determination of Huntington's disease neuropathy

    Brain